Today, the FDA approved the latest drug to treat hepatitis C. Manufactiured by Gilead, a combination of Ledipasvir and Sofosbuvir, it has a better than 95% cure rate. Called Harvoni, it will be available shortly for patients. For more information, call our office at 713-794-0700 for more details.